Division of Colon and Rectal Surgery, Jewish General Hospital, McGill University, 3755 Cote Ste Catherine, G-317, Montreal, Quebec, H3T 1E2, Canada.
Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.
J Gastrointest Surg. 2019 Feb;23(2):348-356. doi: 10.1007/s11605-018-3974-8. Epub 2018 Sep 27.
There is ongoing debate regarding the benefits of minimally invasive techniques for rectal cancer surgery. The aim of this study was to compare pathologic outcomes of patients who underwent rectal cancer resection by open surgery, laparoscopy, and robotic surgery using the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) proctectomy-targeted database.
All patients from the 2016 ACS-NSQIP proctectomy-targeted database who underwent elective proctectomy for rectal cancer were identified. Patients were divided into three groups based on initial operative approach: open surgery, laparoscopy, and robotic surgery. Pathologic and 30-day clinical outcomes were then compared between the groups. A propensity score analysis was performed to control for confounders, and adjusted odds ratios for pathologic outcomes were reported.
A total of 578 patients were included-211 (36.5%) in the open group, 213 (36.9%) in the laparoscopic group, and 154 (26.6%) in the robotic group. Conversion to open surgery was more common among laparoscopic cases compared to robotic cases (15.0% vs. 6.5%, respectively; p = 0.011). Positive circumferential resection margin (CRM) was observed in 4.7%, 3.8%, and 5.2% (p = 0.79) of open, laparoscopic, and robotic resections, respectively. Propensity score adjusted odds ratios for positive CRM (open surgery as a reference group) were 0.70 (0.26-1.85, p = 0.47) for laparoscopy and 1.03 (0.39-2.70, p = 0.96) for robotic surgery.
The use of minimally invasive surgical techniques for rectal cancer surgery does not appear to confer worse pathologic outcomes.
对于直肠癌手术的微创技术的益处,目前仍存在争议。本研究旨在使用美国外科医师学会国家外科质量改进计划(ACS-NSQIP)直肠切除术靶向数据库,比较接受开放式手术、腹腔镜手术和机器人手术的直肠癌患者的病理结果。
从 2016 年 ACS-NSQIP 直肠切除术靶向数据库中确定所有接受择期直肠切除术治疗直肠癌的患者。根据初始手术方法将患者分为三组:开放式手术、腹腔镜手术和机器人手术。然后比较组间的病理和 30 天临床结果。进行倾向评分分析以控制混杂因素,并报告病理结果的调整比值比。
共纳入 578 例患者-211 例(36.5%)在开放式组,213 例(36.9%)在腹腔镜组,154 例(26.6%)在机器人组。与机器人手术相比,腹腔镜手术中更常见转为开放式手术(分别为 15.0%和 6.5%;p=0.011)。阳性环周切缘(CRM)分别在开放式、腹腔镜和机器人切除术中观察到 4.7%、3.8%和 5.2%(p=0.79)。在倾向评分调整后,阳性 CRM 的比值比(以开放式手术为参考组)分别为腹腔镜手术 0.70(0.26-1.85,p=0.47)和机器人手术 1.03(0.39-2.70,p=0.96)。
微创技术在直肠癌手术中的应用似乎不会导致更差的病理结果。